Table 1.
Participant | Sex | Age | Etiology | Profound deafness (years) | CI experience (years) | Device | Processor |
---|---|---|---|---|---|---|---|
CI1 | F | 58 | Idiopathic | 18 | 2.8 | Med-El SonataTi100 | Opus II |
CI2 | M | 61 | Meniere’s | 4 | 3.7 | Med-El SonataTi100 | Opus II |
CI3a | F | 47 | Autoimmune | 9 | 3 | Med-El SonataTi100 | Opus II |
CI4a | M | 35 | Idiopathic | 4 | 2.3 | ABC HiRes 90K | Harmony |
CI5 | M | 58 | Meniere’s | 11 | 11 | ABC Clarion | Harmony |
CI6a | M | 57 | Meniere’s | 3 | 2.2 | Med-El SonataTi100 | Opus II |
CI7a | F | 56 | Idiopathic | 7 | 4.9 | ABC HiRes 120 | Harmony |
CI8a | M | 51 | Idiopathic | 15 | 14.3 | ABC HiRes 120 | Harmony |
CI9 | F | 47 | Autoimmune | 1 | 1 | Med-El SonataTi100 | Opus II |
CI10a | F | 58 | Autoimmune | 15 | 2 | ABC Clarion CII | Harmony |
CI11 | F | 26 | Meniere’s | 8 | 3.7 | CC Nucleus 22 | Freedom |
CI12a | F | 41 | Idiopathic | 4 | 1.5 | ABC HiRes 90K | Harmony |
Note: ABC = Advanced Bionics Corporation; CC = Cochlear Corporation; F = female; M = male.
These participants were bilateral CI recipients; demographics correspond to implant side with that was tested in this study.